Digitoxigenin mono-β-D-digitoxoside

CAS: 18404-43-8

Ref. 3D-TAA40443

Produktinformation

• Name: Digitoxigenin mono-β-D-digitoxoside
• Marke: Biosynth
• Beschreibung: Digitoxigenin mono-β-D-digitoxoside is a potent inhibitor of tumor growth and cancer cell proliferation. It is an analog of the cardiac glycoside digitoxin, which is known for its anticancer properties. Digitoxigenin mono-β-D-digitoxoside has been shown to induce apoptosis in human cancer cells by inhibiting protein kinases such as AKT and ERK1/2. This drug also has potential therapeutic applications in the treatment of ghrelin-related diseases, as it has been shown to inhibit the activity of ghrelin, a hormone that stimulates appetite and promotes weight gain. Additionally, digitoxigenin mono-β-D-digitoxoside exhibits high water solubility due to its cellulose-based structure, making it ideal for use in urine-based diagnostic tests for cancer detection.

Chemische Eigenschaften

• Molekulargewicht: 504.7 g/mol
• Formel: C₂₉H₄₄O₇
• Reinheit: Min. 95%